CDT Equity (CDT) Profit After Tax (2022 - 2026)
CDT Equity's (CDT) quarterly Profit After Tax came in at -$4.1 million in Q1 2026, up 15.72% YoY from -$3.5 million in Q1 2025, and up 80.95% on a QoQ basis from -$21.3 million in Q4 2025.
CDT Equity (CDT) Profit After Tax (2022 - 2026) Analysis & Trends
CDT Equity (CDT) has 5 years of Profit After Tax data on file, last reported at -$4.1 million in Q1 2026.
- Quarterly Profit After Tax rose 15.72% year-over-year to -$4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$38.7 million (down 102.75% YoY) and the FY2025 annual result came in at -$39.2 million, down 120.37% from the prior year.
- Profit After Tax grew to -$4.1 million in Q1 2026, from -$21.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $3.2 million in Q3 2023 to a low of -$21.3 million in Q4 2025.
- A 5-year average of -$3.9 million and a median of -$3.6 million in 2024 frame the typical range for Profit After Tax.
- The widest YoY moves for Profit After Tax: up 438.39% in 2023, down 1374.4% in 2023.
- Tracing CDT's Profit After Tax over 5 years: stood at $1.3 million in 2022, then plunged by 517.08% to -$5.3 million in 2023, then surged by 54.45% to -$2.4 million in 2024, then plunged by 787.39% to -$21.3 million in 2025, then soared by 80.95% to -$4.1 million in 2026.
- The last three Profit After Tax figures came in at -$4.1 million (Q1 2026), -$21.3 million (Q4 2025), and -$7.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - | -4.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.71 Mn |
| Mar 31, 2026 | -4.06 Mn |
| Dec 31, 2025 | -21.32 Mn |
| Sep 30, 2025 | -7.17 Mn |
| Jun 30, 2025 | -6.11 Mn |
| Mar 31, 2025 | -4.82 Mn |
| Dec 31, 2024 | -2.40 Mn |
| Sep 30, 2024 | -6.46 Mn |
| Jun 30, 2024 | -5.38 Mn |
| Mar 31, 2024 | -3.55 Mn |
| Dec 31, 2023 | -5.28 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Jun 30, 2023 | -1.73 Mn |
| Mar 31, 2023 | -1.94 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | -956,000.00 |
| Jun 30, 2022 | -117,539.00 |
| Mar 31, 2022 | -253,536.00 |